$AKRX News 6 stocks to watch 2:10 p.m. Oct. 22
Post# of 44984
Posted On: 11/11/2014 1:12:00 PM
$AKRX News
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Follow through is the key for speculators 1:05 p.m. Oct. 21, 2014 - The Trading Deck
Volume a sign of the Nasdaq’s weakened state 1:11 p.m. Oct. 7, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 9:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 11:34 a.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 7:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 11:11 a.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 10:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 4:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 7:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 11:07 a.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 6:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 11:09 a.m. Dec. 23, 2011 - Michael Ashbaugh
S&P, Nasdaq retest major support 11:51 a.m. Dec. 12, 2011 - Michael Ashbaugh
U.S. markets survive test of major support 9:57 a.m. Nov. 2, 2011 - Michael Ashbaugh
Zacks Rank #1 Additions for Tuesday - Tale of the Tape 9:30 a.m. Today - Zacks.com
10-Q: AKORN INC 4:48 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Akorn (AKRX) Downgraded From Buy to Hold 9:19 a.m. Nov. 10, 2014 - TheStreet.com
Analysts' Actions: American Eagle, Boulder Brands, HealthStream, Carrizo 8:56 a.m. Nov. 10, 2014 - TheStreet.com
Health Sell-Offs Drag On IBD 50 6:31 p.m. Nov. 7, 2014 - Investors Business Daily
Salix Dives On Earnings, Probe; Akorn A Bad Seed Too 5:55 p.m. Nov. 6, 2014 - Investors Business Daily
A/D Rating Helps Spot What The Pros Are Buying 5:41 p.m. Nov. 6, 2014 - Investors Business Daily
Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript 4:17 p.m. Nov. 6, 2014 - Seeking Alpha
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results 3:50 p.m. Nov. 6, 2014 - TheStreet.com
Akorn Reports 'Messy' Quarter, Slamming Stock 12:19 p.m. Nov. 6, 2014 - Investors Business Daily
Insider Trading Alert - PAY, GRPN And AKRX Traded By Insiders 10:15 a.m. Nov. 6, 2014 - TheStreet.com
Akorn (AKRX) Q3 2014 Results - Earnings Call Webcast 9:55 a.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Nov. 5, 2014 - Seeking Alpha
Let Major Indexes Dictate Buy, Sell Decisions 5:01 p.m. Nov. 5, 2014 - Investors Business Daily
3 IBD 50 Tech, Drug Stocks With Earnings Thursday 1:49 p.m. Nov. 5, 2014 - Investors Business Daily
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - benzinga.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
Akorn (AKRX): Today's Post-Market Laggard 6:53 p.m. Nov. 4, 2014 - TheStreet.com
Akorn Carves Out Rare Short-Stroke Pattern 5:09 p.m. Nov. 4, 2014 - Investors Business Daily
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap 7:02 a.m. Nov. 4, 2014 - Investors Business Daily
Akorn Reports Preliminary 2014 Third Quarter Results 7:31 a.m. Nov. 6, 2014 - GlobeNewswire
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information 10:04 a.m. Oct. 21, 2014 - GlobeNewswire
Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. 3:22 p.m. Sept. 30, 2014 - BusinessWire - BZX
Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion 3:16 p.m. Sept. 30, 2014 - GlobeNewswire
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 7:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 7:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 5:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 10:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 5:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 10:11 a.m. June 20, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 3:05 p.m. June 16, 2014 - BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte 7:00 a.m. June 5, 2014 - PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 6:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 10:30 a.m. May 9, 2014 - PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million 8:19 a.m. May 9, 2014 - BusinessWire - BZX
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Follow through is the key for speculators 1:05 p.m. Oct. 21, 2014 - The Trading Deck
Volume a sign of the Nasdaq’s weakened state 1:11 p.m. Oct. 7, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 9:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 11:34 a.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 7:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 11:11 a.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 10:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 4:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 7:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 11:07 a.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 6:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 11:09 a.m. Dec. 23, 2011 - Michael Ashbaugh
S&P, Nasdaq retest major support 11:51 a.m. Dec. 12, 2011 - Michael Ashbaugh
U.S. markets survive test of major support 9:57 a.m. Nov. 2, 2011 - Michael Ashbaugh
Zacks Rank #1 Additions for Tuesday - Tale of the Tape 9:30 a.m. Today - Zacks.com
10-Q: AKORN INC 4:48 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Akorn (AKRX) Downgraded From Buy to Hold 9:19 a.m. Nov. 10, 2014 - TheStreet.com
Analysts' Actions: American Eagle, Boulder Brands, HealthStream, Carrizo 8:56 a.m. Nov. 10, 2014 - TheStreet.com
Health Sell-Offs Drag On IBD 50 6:31 p.m. Nov. 7, 2014 - Investors Business Daily
Salix Dives On Earnings, Probe; Akorn A Bad Seed Too 5:55 p.m. Nov. 6, 2014 - Investors Business Daily
A/D Rating Helps Spot What The Pros Are Buying 5:41 p.m. Nov. 6, 2014 - Investors Business Daily
Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript 4:17 p.m. Nov. 6, 2014 - Seeking Alpha
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results 3:50 p.m. Nov. 6, 2014 - TheStreet.com
Akorn Reports 'Messy' Quarter, Slamming Stock 12:19 p.m. Nov. 6, 2014 - Investors Business Daily
Insider Trading Alert - PAY, GRPN And AKRX Traded By Insiders 10:15 a.m. Nov. 6, 2014 - TheStreet.com
Akorn (AKRX) Q3 2014 Results - Earnings Call Webcast 9:55 a.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Nov. 5, 2014 - Seeking Alpha
Let Major Indexes Dictate Buy, Sell Decisions 5:01 p.m. Nov. 5, 2014 - Investors Business Daily
3 IBD 50 Tech, Drug Stocks With Earnings Thursday 1:49 p.m. Nov. 5, 2014 - Investors Business Daily
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - benzinga.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
Akorn (AKRX): Today's Post-Market Laggard 6:53 p.m. Nov. 4, 2014 - TheStreet.com
Akorn Carves Out Rare Short-Stroke Pattern 5:09 p.m. Nov. 4, 2014 - Investors Business Daily
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap 7:02 a.m. Nov. 4, 2014 - Investors Business Daily
Akorn Reports Preliminary 2014 Third Quarter Results 7:31 a.m. Nov. 6, 2014 - GlobeNewswire
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information 10:04 a.m. Oct. 21, 2014 - GlobeNewswire
Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. 3:22 p.m. Sept. 30, 2014 - BusinessWire - BZX
Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion 3:16 p.m. Sept. 30, 2014 - GlobeNewswire
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 7:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 7:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 5:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 10:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 5:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 10:11 a.m. June 20, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 3:05 p.m. June 16, 2014 - BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte 7:00 a.m. June 5, 2014 - PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 6:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 10:30 a.m. May 9, 2014 - PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million 8:19 a.m. May 9, 2014 - BusinessWire - BZX
(0)
(0)